Details for New Drug Application (NDA): 075191
✉ Email this page to a colleague
The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
Summary for 075191
Tradename: | PENTOXIFYLLINE |
Applicant: | Apotex |
Ingredient: | pentoxifylline |
Patents: | 0 |
Pharmacology for NDA: 075191
Physiological Effect | Hematologic Activity Alteration |
Medical Subject Heading (MeSH) Categories for 075191
Suppliers and Packaging for NDA: 075191
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 075191 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8305 | 0615-8305-39 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8305-39) |
PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 075191 | ANDA | Major Pharmaceuticals | 0904-5448 | 0904-5448-61 | 100 BLISTER PACK in 1 CARTON (0904-5448-61) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 400MG | ||||
Approval Date: | Jun 9, 1999 | TE: | AB | RLD: | No |
Complete Access Available with Subscription